SCHEMBL30359478

SCHEMBL30359478

Cc1ccnc2ccc(-c3c(-c4ccc(F)cc4)nc(N)c4nnnn34)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK14 Q16539 8/20 0.40
▸ MAPK13 O15264 2/20 0.40
▸ MAPK12 P53778 2/20 0.40
▸ MAPK11 Q15759 2/20 0.40
▸ KDM4E B2RXH2 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ SMN1; SMN2 Q16637 2/20 0.38
▸ HSD17B10 Q99714 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ HCRTR1 O43613 1/20 0.38
▸ USP2 O75604 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ CASP3 P42574 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ SENP8 Q96LD8 1/20 0.38
▸ SENP7 Q9BQF6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25206204 1.00 MAPK14 (0.40) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL25205150 0.91 MAPK1 (0.41) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL30359474 0.90 KDM4E (0.38) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL25206143 0.90 KDM4E (0.38) MAPK14MAPK13MAPK12MAPK11KDM4E
SCHEMBL30359459 0.90 MAP4K4 (0.38) MAPK14KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL25230127 0.90 MAP4K4 (0.38) MAPK14KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL30359483 0.88 MAP4K4 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL25255165 0.88 MAP4K4 (0.40) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL25235560 0.87 MAP4K4 (0.39) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10
SCHEMBL30359464 0.87 MAP4K4 (0.39) KDM4EALDH1A1HPGDSMN1; SMN2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4433485-A1 ADENOSINE RECEPTOR ANTAGONISTS Crossignal Therapeutics, Inc. (US) 2024-09-25 — — EP claimed
WO-2023091604-A1 ADENOSINE RECEPTOR ANTAGONISTS CROSSIGNAL THERAPEUTICS, INC. (US) 2023-05-25 — — WO claimed
EP-4433485-A1 ADENOSINE RECEPTOR ANTAGONISTS Crossignal Therapeutics, Inc. (US) 2024-09-25 — — EP disclosed
WO-2023091604-A1 ADENOSINE RECEPTOR ANTAGONISTS CROSSIGNAL THERAPEUTICS, INC. (US) 2023-05-25 — — WO disclosed
Send feedback